tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Akero Therapeutics (DE:0K4)
:0K4
Germany Market
0K4
Akero Therapeutics
Overview
Analyst Forecasts
Financials
Dividends
Technical Analysis
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Akero Therapeutics (0K4) Stock News & Sentiment

Compare
2 Followers
Akero Therapeutics: Strong Financials and Promising Clinical Progress Justify Buy Rating
Premium
Ratings
Akero Therapeutics: Strong Financials and Promising Clinical Progress Justify Buy Rating
8d ago
AKRO
Promising Developments and Strong Financial Position Support Buy Rating for Akero Therapeutics
Premium
Ratings
Promising Developments and Strong Financial Position Support Buy Rating for Akero Therapeutics
8d ago
AKRO
Akero Therapeutics: Buy Rating Backed by Groundbreaking Clinical Results and Strong Financial Position
Premium
Ratings
Akero Therapeutics: Buy Rating Backed by Groundbreaking Clinical Results and Strong Financial Position
9d ago
AKRO
Akero Therapeutics Reports Promising Clinical Trial Results
Premium
Company Announcements
Akero Therapeutics Reports Promising Clinical Trial Results
10d ago
AKRO
Akero Therapeutics: Strong Financial Health and Promising Clinical Trial Results Drive Buy Rating
Premium
Ratings
Akero Therapeutics: Strong Financial Health and Promising Clinical Trial Results Drive Buy Rating
11d ago
AKRO
Akero Shares Skyrocket as MASH Drug Delivers Game-Changing Results
Premium
Market News
Akero Shares Skyrocket as MASH Drug Delivers Game-Changing Results
1M ago
LLY
AKRO
Akero Therapeutics Reports Promising Phase 2b Study Results
Premium
Company Announcements
Akero Therapeutics Reports Promising Phase 2b Study Results
1M ago
8K
AKRO
More DE:0K4 News >

0K4 News on the Web

Evercore ISI Reaffirms Their Buy Rating on Akero Therapeutics (AKRO)
TipRanks News
Neutral
Is Agilon Health Outperforming Other Medical Stocks This Year?
Yahoo Finance
Neutral
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
Zacks
Neutral
Why Akero Therapeutics, Inc. is Skyrocketing So Far in 2025
Yahoo Finance
Neutral
Bank of America Securities Remains a Buy on Akero Therapeutics (AKRO)
TipRanks News
Neutral
Akero Therapeutics Reports Promising Clinical Trial Results
TipRanks News
Neutral
3 Mid-Caps Worth Watching Closely in March
MarketBeat
Neutral
Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
DE:0K4
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.75 articles
News Sentiment
This Week59%
Sector Average53%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:0K4’s Media Buzz Sentiment?
3 articles about DE:0K4 were published this week. In an average week, 2.75 articles are published.
    What is DE:0K4’s weekly average amount of articles?
    In an average week, 2.75 articles about DE:0K4 are published.
      What is DE:0K4’s News Sentiment?
      59% of articles about DE:0K4 were positive this week, compared to its sector average of 53%.
        Healthcare Stocks that are Trending in the News
        JAZZJazz Pharmaceuticals
        FENCFennec Pharmaceuticals
        CKPTCheckpoint Therapeutics
        NVONovo Nordisk
        LCTXLineage Therap
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing